You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

 

Online download statistics by month:

Online download statistics by month: September 2022 to September 2024

AbstractFullPdf
Sep 202218218732
Oct 2022430440145
Nov 202217818192
Dec 202210310436
Jan 2023848628
Feb 2023878737
Mar 2023576441
Apr 2023525425
May 2023373721
Jun 2023505133
Jul 2023303017
Aug 2023494816
Sep 2023404118
Oct 2023242415
Nov 2023444615
Dec 2023464725
Jan 2024444528
Feb 2024272717
Mar 2024474762
Apr 2024525332
May 2024383923
Jun 2024383720
Jul 2024646423
Aug 2024312911
Sep 20243636118
Total18701904930